Press Releases

Jun 1, 2026

Caleb Monroe

Press Releases

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Aprea Therapeutics presented updated Phase 1 clinical trial data for their oral WEE1 inhibitor, APR-1051, at ASCO 2026. The data demonstrated preliminary anti-tumor activity, including partial responses and stable disease in heavily pretreated patients with advanced solid tumors, along with a favorable safety and tolerability profile. Enrollment is…

APRE

Jun 1, 2026

Caleb Monroe

Press Releases

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI, Inc. announced the results of its 2026 Annual Meeting confirming all shareholder proposals, including board elections and audit firm ratification. The company highlighted its receipt of FDA De Novo classification for the DeepView System, enabling commercial distribution in the U.S. It also secured $31.7 million funding from BARDA, expa…

MDAI

Jun 1, 2026

Ajmal Hussain

Press Releases

BCB Appoints New CEO

BCB Bancorp, Inc., a New Jersey-based community bank holding company, has appointed Thomas M. O'Brien as President and Chief Executive Officer effective June 1, 2026. O'Brien brings extensive experience in community banking and aims to address recent operational and credit challenges faced by the company while focusing on regulatory compliance, cos…

BCBP

Jun 1, 2026

Hana Yamamoto

Press Releases

Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Lyell Immunopharma announced that its senior management will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026, highlighting its progress in developing next-generation CAR T-cell therapies for cancer, and revealing its commercial manufacturing capacity to support product launches.

LYEL

Jun 1, 2026

Priya Menon

Press Releases

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

ALX Oncology Holdings Inc., a clinical-stage biotech company focusing on novel cancer treatments, announced its participation in a fireside chat at the 2026 Jefferies Global Healthcare Conference. The company highlighted its lead candidate evorpacept, advancing through multiple clinical trials, and its second candidate ALX2004 currently in a Phase …

ALXO

Jun 1, 2026

Nina Shah

Press Releases

MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology

MAIA Biotechnology presented a Trial in Progress poster at the 2026 ASCO Annual Meeting detailing its pivotal Phase 3 clinical trial THIO-104, evaluating the efficacy of its novel telomere-targeting agent ateganosine in combination with checkpoint inhibitors for third-line treatment in non-small cell lung cancer patients resistant to current therap…

MAIA

Jun 1, 2026

Marcus Reed

Press Releases

Outdoor Holding Company Appoints Director of AI Strategy & Implementation

Outdoor Holding Company (Nasdaq: POWW), the owner of GunBroker.com, appointed Erich Buerger as Director of AI Strategy & Implementation to lead the company’s AI initiatives. This strategic hire aims to enhance marketplace functionality, operational efficiency, and long-term shareholder value through disciplined AI deployment aligned with the compan…

POWW

Jun 1, 2026

Ajmal Hussain

Press Releases

Kaltura Named an Exemplary Provider in ISG Research Buyers Guide on Conversational AI

Kaltura has been named an Exemplary Provider in the ISG Research Buyers Guide on Conversational AI Emerging Providers. This accolade recognizes Kaltura's innovative conversational and agentic AI platform that enables personalized, real-time, context-aware digital engagement across multiple sectors. The company is expanding its AI capabilities throu…

KLTR

Jun 1, 2026

Caleb Monroe

Press Releases

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Beyond Air, Inc. announced that the Nasdaq Hearings Panel has approved its request to continue listing on Nasdaq, provided the company regains compliance with the bid price requirement by July 31, 2026. The company plans to hold a shareholder vote on a reverse stock split to meet this requirement and remains focused on advancing its commercial and …

XAIR

Jun 1, 2026

Nina Shah

Press Releases

Agora, Inc. Announces Management Share Purchase Plan

Agora, Inc., a leader in conversational AI and real-time engagement technology, announced that its CEO Tony Zhao intends to invest up to $20 million in the company’s shares over the next 12 months. This management share purchase plan aims to demonstrate confidence in the company's growth prospects amid expanding market opportunities in real-time en…

API

Jun 1, 2026

Avery Klein

Press Releases

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Immatics N.V. presented extended Phase 1b clinical trial data for its anzu-cel (IMA203) PRAME-targeted TCR T-cell therapy at the 2026 ASCO Annual Meeting, showing rapid, deep, and durable anti-tumor responses in heavily pretreated metastatic melanoma patients, including cutaneous and uveal subtypes. The therapy demonstrated a 56% confirmed overall …

IMTX

Jun 1, 2026

Ajmal Hussain

Press Releases

Viasat Selected by Lockheed Martin to Support NOAA Next-Generation Aircraft with Hybrid Satellite Communications Platform

Viasat Inc. has been selected by Lockheed Martin to supply high-bandwidth satellite communications technology for NOAA’s next-generation C-130J 'Hurricane Hunter' aircraft. This contract involves delivering Viasat's Hybrid SATCOM Approach technology to enable resilient, real-time data transmission supporting hurricane forecasting and severe weather…

VSAT

Jun 1, 2026

Derek Hwang

Press Releases

zSpace Eliminates Over $12 Million in Debt Through Conversion to Equity

zSpace, Inc., a provider of immersive augmented and virtual reality learning technology, announced it has converted more than $12 million of its outstanding debt into equity through agreements with lenders. This transaction eliminates related debt obligations, thus improving the company's financial foundation and enabling focus on its growth in edu…

ZSPC

Jun 1, 2026

Priya Menon

Press Releases

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

Senseonics Holdings announced plans for an analyst event and an oral presentation at the upcoming ADA 2026 Scientific Sessions to showcase recent commercial milestones and new real-world evidence for their implantable Eversense 365 Continuous Glucose Monitoring system. These events will focus on the system's performance, integration with insulin pu…

SENS

Jun 1, 2026

Leila Farooq

Press Releases

OpenPayd Targets Nasdaq Listing at Unicorn Valuation

OpenPayd has announced a definitive business combination with Titan Acquisition Corp. to become a publicly traded company on Nasdaq under the ticker OP. Valued at $1.145 billion on a pro-forma basis, OpenPayd operates a global financial infrastructure platform bridging traditional finance with digital assets, including stablecoins, via a single API…

OP

Jun 1, 2026

Ajmal Hussain

Press Releases

Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

Jasper Therapeutics, a clinical-stage biotech company focused on developing briquilimab for mast cell driven diseases, announced its Board of Directors will evaluate various strategic alternatives including asset sales, collaborations, merger, or wind-down, aiming to maximize shareholder value amid current market challenges. The company continues t…

JSPR

Jun 1, 2026

Hana Yamamoto

Press Releases

Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement

Ten-League International Holdings Limited, a Singapore-based turnkey project solutions provider, announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. Following a Nasdaq Hearings Panel review, the company was granted continued listing conditioned upon demonstrating compliance, which it has now achieved…

TLIH

Jun 1, 2026

Ajmal Hussain

Press Releases

Vertex to Present at the 46th Annual William Blair Growth Stock Conference

Vertex, Inc., a leader in enterprise compliance technology, will present at the 46th Annual William Blair Growth Stock Conference to discuss its AI-powered tax automation solutions that help global enterprises manage complex tax processes efficiently. The presentation aims to highlight the company's expertise and growth strategy in the compliance t…

VERX

Jun 1, 2026

Hana Yamamoto

Press Releases

STEALTHGAS INC. Announces the Date for the Release of the First Quarter 2026 Financial and Operating Results, Conference Call and Webcast

STEALTHGAS INC., a ship-owning company serving the international liquefied petroleum gas (LPG) shipping sector, announced it will release its first quarter 2026 financial and operating results on June 5, 2026. The company will host a conference call and webcast to discuss the results and outlook.

GASS

Jun 1, 2026

Priya Menon

Press Releases

NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026

NextCure presented promising Phase 1 dose escalation data for SIM0505, a novel anti-CDH6 antibody-drug conjugate targeting platinum-resistant ovarian cancer (PROC) and uterine serous carcinoma (USC). The study reported a 55% overall response rate in gynecologic cancers, with favorable safety and tolerability profiles. These results support ongoing …

NXTC

Jun 1, 2026

Leila Farooq

Press Releases

Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease

Voyager Therapeutics announced FDA clearance of its Investigational New Drug (IND) application for VY1706, the company's gene therapy targeting tau protein to treat Alzheimer's disease (AD). This first-of-its-kind therapy uses an intravenous brain-targeted capsid to reduce tau production, with clinical dosing expected in the second half of 2026. Pr…

VYGR

Jun 1, 2026

Ajmal Hussain

Press Releases

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Amneal Pharmaceuticals, a diversified biopharmaceutical company specializing in affordable and innovative medicines, announced that Co-CEO Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The presentation will be webcast live and provide insights into the company's diverse portfolio and growth…

AMRX

Jun 1, 2026

Avery Klein

Press Releases

Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company’s AMP-DNA Adjuvant Technology

Elicio Therapeutics announced the publication of a peer-reviewed study in Science Advances detailing the potent immune responses generated by their novel AMP-DNA adjuvant platform. The preclinical research highlights superior efficacy, durable T cell activation, and a distinct lymph node-targeted mechanism, reinforcing the versatility and potential…

ELTX

Jun 1, 2026

Jordan Park

Press Releases

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma

Aura Biosciences announced the completion of enrollment for 108 patients in its pivotal Phase 3 CoMpass trial testing belzupacap sarotalocan (bel-sar) as a frontline, vision-preserving treatment for early choroidal melanoma. Topline data from the 15-month primary endpoint are anticipated in the second half of 2027, marking a key milestone toward po…

AURA

Jun 1, 2026

Derek Hwang

Press Releases

Bitdeer Launches SEALMINER DL1 Hydro Achieving 52.5 GH/s and 149 J/GH Power Efficiency

Bitdeer Technologies Group announced the launch of the SEALMINER DL1 Hydro, a new hydro-cooled mining machine optimized for the Scrypt algorithm. The device achieves a hashrate of 52.5 GH/s with an energy efficiency of 149 J/GH, supporting coins like Litecoin and Dogecoin. The hydro-cooling design aims to improve operational stability and power eff…

BTDR